Related Experiment Video
Updated: Jan 14, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Long-term Effect of Pulmonary Rehabilitation in Pulmonary Tuberculosis Patients
Munazzah Orooj1, Amit Saraf2, Aqsa Mujaddadi3
1Department of Physiotherapy, Teerthanker Mahaveer University, Moradabad, India.
Objective:
Post-pulmonary tuberculosis (post-PTB) sequelae, including impaired lung function, reduced exercise capacity, and diminished quality of life (QoL), pose significant challenges even after successful anti-tuberculosis treatment. While pulmonary rehabilitation (PR) is an established intervention for chronic respiratory diseases, its long-term effectiveness in post-PTB patients is not well-documented. This study aimed to evaluate the long-term impact of an 8-week outpatient PR program on respiratory function, exercise performance, and QoL in post-PTB patients.
Material And Methods:
In a randomized controlled trial, 90 post-PTB patients aged ≥18 years were allocated to either the PR group or a control group. The PR program included supervised endurance and resistance training, breathing exercises, and patient education, delivered over 8 weeks. Primary outcomes, including the 6-minute walk distance (6MWD), Saint George's Respiratory Questionnaire (SGRQ), and pulmonary function tests, were assessed at baseline, immediately post-intervention, and at 12 months. Data were analyzed using repeated measures ANOVA.
Results:
The PR group demonstrated significant and sustained improvements across all measures. The 6MWD increased by 217 meters post-PR and remained 143 meters higher at 12 months (P < 0.05). SGRQ scores showed a 28-point reduction post-PR and a 32-point reduction at 12 months (P < 0.05). FEV1 improved by 41% post-PR, and by 45% at 12 months (P < 0.05). No significant changes were observed in the control group.
Conclusion:
An 8-week PR program delivers long-term benefits in respiratory function, exercise capacity, and QoL in post-PTB patients. Incorporating PR into post-PTB care is a promising strategy to mitigate chronic sequelae and enhance patient outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumothorax-II
Clinical Manifestations:

